Literature DB >> 12946744

Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients.

Peder Gjengstø1, Ole Johan Halvorsen, Lars Andreas Akslen, Jannicke Frugård, Per Aage Hoisaeter.   

Abstract

OBJECTIVES: To study, in a selected series of patients, whether the peripheral/central zone volumes also change with age. The reported normal total prostate volume in the third decade seems not to exceed 25 to 30 cm(3). Benign prostatic hyperplasia is generally accepted to originate in the transition zone and periurethral tissue, which accordingly show substantial growth with age.
METHODS: From January 1997 through December 2000, we performed transrectal ultrasound volume measurements of the different prostate zones in patients admitted for suspected prostate cancer. The information was registered according to a prospectively designed protocol. A total of 872 patients were examined, of whom 360 shown to have prostate cancer were excluded. Two more patients were excluded because of missing volume data, leaving 510 patients with noncancerous prostates for inclusion in this study.
RESULTS: The mean age was 62.8 years and the mean total prostate-specific antigen level was 9.8 microg/L. It was found that 64.9% (331 of 510) had a peripheral/central zone volume larger than 30 cm(3), indicating that some form of growth had occurred also in this zone. A weak but significant correlation was found between age and the peripheral/central zone volume.
CONCLUSIONS: The results of our study indicate that the peripheral/central zone may contribute to the benign growth of the prostate gland in men younger than 70 years old with slightly elevated total prostate-specific antigen levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946744     DOI: 10.1016/s0090-4295(03)00410-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry.

Authors:  Benedikt Kranzbühler; Oliver Gross; Christian D Fankhauser; Marian S Wettstein; Nico C Grossmann; Lukas J Hefermehl; Matthias Zimmermann; Alexander Müller; Daniel Eberli; Tullio Sulser; Cédric Poyet; Thomas Hermanns
Journal:  World J Urol       Date:  2016-06-23       Impact factor: 4.226

2.  Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy.

Authors:  Henry H Woo; Ricardo R Gonzalez
Journal:  Med Devices (Auckl)       Date:  2017-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.